EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Losartan API and Nitrosamines Impurities—Stability Profile Investigation Using HPLC, LC‐MS, and In Silico Assessment

Paulo Roberto Rodrigues Martini, Lilian Fanfa Machioli, Bruno Pereira Dos Santos, Tiago Franco de Oliveira, Fávero Reisdorfer Paula, Clésio Soldateli Paim, Andreas Sebastian Loureiro Mendez

Journal of Separation Science · 2026-05 · 49 (5)

DOI: 10.1002/jssc.70438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Separation Science, online erschienen am 08.05.2026. Verfasst von Paulo Roberto Rodrigues Martini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduation Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Losartan, Nitrosamines, Drug Contamination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian National Council for Scientific and Technological Development (CNPq), Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitrosamines are potent genotoxic impurities with well reported mutagenic and carcinogenic effects. Their presence has been detected in several pharmaceutical products among them losartan, an angiotensin II receptor blocker. Considering the risks already reported for these impurities, the present study aimed to investigate the influence of four common nitrosamines—N‐nitrosodimethylamine (NDMA), N‐nitrosodiethylamine (NDEA), N‐nitrosodiisopropylamine (NDIPA), and N‐nitrosodibutylamine (NDBA)—in the stability profile of losartan API. Quantitative assay was conducted through HPLC and LC‐MS, with focus on monitoring degradation rate and degradation products under influence of nitrosamines. Predictive data by in silico investigation employing Zeneth Nexus and Spartan were simultaneously studied, considering degradation products, fragmentation pathway and nitrosamines reactivity. The drug residual content showed variability depending on the nitrosamine evaluated and the stressing condition applied. From photolysis, for example the residual content ranged 80%–90%, with a greater decomposition in samples containing nitrosamines. A greater decomposition was also observed in oxidative degradation, with exception for samples containing NDMA. Acid and basic media caused a significant decomposition, with the residual losartan content in a range of 41%–52% and 28%–51%, respectively. From LC‐MS analyzes, these impurities were mostly not detected in the degraded samples, suggesting their consumption during the reaction due to their reactivity. A protective effect from nitrosamines can be also reported possibly due to their reactivity against the stressing factor. Seven degradation products were structurally proposed by LC‐MS at m / z 449, m / z 447, m / z 366, m / z 338, m / z 274, m / z 391, and m / z 341, some of them predicted computationally by Zeneth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LosartanNitrosaminesDrug ContaminationChromatography, High Pressure LiquidLiquid Chromatography-Mass SpectrometryMass SpectrometryComputer SimulationDrug Stability

Stichwörter der Autor:innen

HPLCLC‐MSdegradation productsin silico modelinglosartannitrosaminesstability

Substanzen

LosartanNitrosamines

Autor:innen und Institutionen

  • Postgraduation Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Postgraduation Program in Health Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil.
  • Postgraduation Program in Pharmaceutical Sciences, Federal University of Pampa (UNIPAMPA), Uruguaiana, Rio Grande do Sul, Brazil.

Förderung

  • Brazilian National Council for Scientific and Technological Development (CNPq)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Martini, P. R. R., Machioli, L. F., Santos, B. P. D., Oliveira, T. F., Paula, F. R., Paim, C. S., & Mendez, A. S. L. (2026). Losartan API and Nitrosamines Impurities—Stability Profile Investigation Using HPLC, LC‐MS, and In Silico Assessment. Journal of Separation Science, 49(5). https://doi.org/10.1002/jssc.70438

Vancouver

Martini PRR, Machioli LF, Santos BPD, Oliveira TF, Paula FR, Paim CS, et al. Losartan API and Nitrosamines Impurities—Stability Profile Investigation Using HPLC, LC‐MS, and In Silico Assessment. Journal of Separation Science. 2026;49(5). doi:10.1002/jssc.70438

BibTeX
@article{Martini2026,
  author = {Martini, Paulo Roberto Rodrigues and Machioli, Lilian Fanfa and Santos, Bruno Pereira Dos and Oliveira, Tiago Franco de and Paula, Fávero Reisdorfer and Paim, Clésio Soldateli and Mendez, Andreas Sebastian Loureiro},
  title = {Losartan API and Nitrosamines Impurities—Stability Profile Investigation Using HPLC, LC‐MS, and In Silico Assessment},
  journal = {Journal of Separation Science},
  year = {2026},
  volume = {49},
  number = {5},
  doi = {10.1002/jssc.70438}
}
Kostenlos starten →